FDA Panel To Review the Amgen’s ABP 501, Biosimilar Candidate To Adalimumab
Amgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.